Nath Bio-Genes (India) Limited (BOM:537291)
India · Delayed Price · Currency is INR 150.00
+0.35 (0.23%)
At close: Feb 13, 2026
Nath Bio-Genes (India) Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 386 | 396.19 | 350.11 | -673.85 | 556.62 |
Depreciation & Amortization | 37.83 | 32.61 | 30.12 | 30.84 | 28.16 |
Other Amortization | 0.33 | - | - | - | - |
Loss (Gain) From Sale of Assets | 10.35 | -0.01 | 0.01 | -0.04 | -0.04 |
Provision & Write-off of Bad Debts | 16.52 | 2.4 | 1.17 | 4.5 | -3.37 |
Other Operating Activities | 74.32 | 83.8 | 100.38 | 998.3 | 81.04 |
Change in Accounts Receivable | 37.56 | 27.65 | -118.83 | 210.23 | -20.58 |
Change in Inventory | -1,077 | -224.63 | 124.96 | 59.57 | -219.92 |
Change in Accounts Payable | 361.87 | 155.61 | -150.46 | 199.92 | -229.73 |
Change in Other Net Operating Assets | 328.11 | 272.32 | 46.2 | -658.99 | -181.05 |
Operating Cash Flow | 175.81 | 745.94 | 383.67 | 170.48 | 11.13 |
Operating Cash Flow Growth | -76.43% | 94.42% | 125.05% | 1431.83% | -88.26% |
Capital Expenditures | -79.2 | -267.76 | -28.81 | -210.04 | -115.47 |
Sale of Property, Plant & Equipment | 1.05 | 0.5 | 0.47 | 0.73 | 1.53 |
Sale (Purchase) of Intangibles | - | - | -0.68 | -0.13 | -0.52 |
Investment in Securities | 2.64 | -9.98 | -0 | -0 | -0.5 |
Other Investing Activities | 35.89 | 3.22 | 0.18 | 10.93 | 12.14 |
Investing Cash Flow | -39.62 | -274.01 | -28.84 | -198.51 | -102.82 |
Short-Term Debt Issued | 40.78 | 59.18 | 133.67 | 24.31 | 248.67 |
Long-Term Debt Issued | 93.3 | 24.24 | - | 0.12 | 3.53 |
Total Debt Issued | 134.08 | 83.42 | 133.67 | 24.43 | 252.2 |
Short-Term Debt Repaid | -0.35 | -32.08 | -8.51 | -102.63 | - |
Long-Term Debt Repaid | -12.18 | - | -2.62 | - | - |
Total Debt Repaid | -12.53 | -32.08 | -11.13 | -102.63 | - |
Net Debt Issued (Repaid) | 121.55 | 51.34 | 122.54 | -78.2 | 252.2 |
Common Dividends Paid | -38.01 | -38.01 | -38.01 | -38.01 | - |
Other Financing Activities | -104.84 | -91.11 | -101.21 | -106.11 | -88.19 |
Financing Cash Flow | -21.3 | -77.78 | -16.68 | -222.32 | 164.01 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 |
Net Cash Flow | 114.9 | 394.15 | 338.15 | -250.36 | 72.31 |
Free Cash Flow | 96.61 | 478.18 | 354.85 | -39.56 | -104.34 |
Free Cash Flow Growth | -79.80% | 34.76% | - | - | - |
Free Cash Flow Margin | 2.65% | 14.37% | 11.77% | -1.42% | -3.39% |
Free Cash Flow Per Share | 5.08 | 25.16 | 18.67 | -2.08 | -5.49 |
Cash Interest Paid | 104.84 | 91.11 | 101.21 | 106.11 | 88.19 |
Cash Income Tax Paid | 10.84 | 3.4 | 9.22 | 28.77 | 3.04 |
Levered Free Cash Flow | 111.33 | 332.4 | 141.3 | 697.65 | -569.41 |
Unlevered Free Cash Flow | 173.2 | 386.33 | 201.14 | 760.93 | -520.02 |
Change in Working Capital | -349.53 | 230.95 | -98.13 | -189.27 | -651.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.